Skip to main content
Faes Farma S.A. logo

Faes Farma S.A. — Investor Relations & Filings

Ticker · FAE ISIN · ES0134950F36 LEI · 959800FXZQY7U3P1G969 MC Manufacturing
Open in API
Filings indexed 193 across all filing types
Latest filing 2017-02-28 Annual Report
Country ES Spain
Listing MC FAE

About Faes Farma S.A.

https://faesfarma.com/en/

Faes Farma S.A. is a pharmaceutical company engaged in the research, development, manufacturing, and marketing of pharmaceutical products, healthcare solutions, and animal nutrition products. The company's pharmaceutical division develops treatments for conditions in therapeutic areas including allergy, gastroenterology, and immunology, with key proprietary molecules such as Bilastine, a leading antihistamine, and Calcifediol for Vitamin D deficiency. The animal nutrition business provides nutritional solutions and supplements for sustainable animal production. A core focus of the company is its investment in R&D to develop novel molecules and health solutions for its global markets.

Recent filings

Filing Released Lang Actions
Annual Report 2016
Annual Report Classification · 100% confidence The document is titled 'Cuentas Anuales Consolidadas' (Consolidated Annual Accounts) for Faes Farma, S.A. for the fiscal year ending December 31, 2016. It includes an independent auditor's report from KPMG, consolidated balance sheets, and consolidated profit and loss statements. As it represents the full annual financial reporting package for the company, it is classified as an Annual Report (10-K). FY 2016
2017-02-28 Spanish
Corporate Governance Report - Faes Farma S.A.
Remuneration Information Classification · 100% confidence The document is explicitly titled "INFORME ANUAL SOBRE REMUNERACIONES DE LOS CONSEJEROS DE SOCIEDADES ANONIMAS COTIZADAS" (Annual Report on Remuneration of Directors of Listed Public Limited Companies). It details the remuneration policy, fixed components, variable components, and the process for determining compensation for the Board of Directors for the fiscal year ending 31/12/2016. This content directly corresponds to the definition of a report detailing compensation for top executives and directors, which maps to the 'Remuneration Information' category. The code for Remuneration Information is DEF 14A, which is defined as: 'Report detailing compensation for top executives and directors.' Although the document is an 'Annual Report on Remuneration,' it is a specific disclosure related to compensation, making DEF 14A the most precise fit over the general 10-K or a general regulatory filing.
2017-02-27 Spanish
Corporate Governance Report - Faes Farma S.A.
Remuneration Information Classification · 100% confidence The document is titled "INFORME ANUAL SOBRE REMUNERACIONES DE LOS CONSEJEROS DE SOCIEDADES ANONIMAS COTIZADAS" (Annual Report on Remuneration of Directors of Listed Public Limited Companies). It explicitly details the remuneration policy, the process for determining it, fixed components, and variable components for directors, referencing the fiscal year end date of 31/12/2015. This content directly corresponds to the disclosure requirements for executive and director compensation, which aligns with the definition of Remuneration Information (DEF 14A in the US context, or similar specific annual governance/remuneration reports in other jurisdictions). Given the specific focus on remuneration details, DEF 14A is the most appropriate classification, even though the document is in Spanish and might be a local equivalent of a proxy statement section.
2016-02-25 Spanish
Annual Report 2015
Annual Report Classification · 100% confidence The document is a comprehensive financial report titled 'Cuentas Anuales Consolidadas' (Consolidated Annual Accounts) for Faes Farma, S.A. for the fiscal year ending December 31, 2015. It includes the Independent Auditor's Report by KPMG, the Consolidated Management Report, and full financial statements (Balance Sheet, Profit and Loss, etc.). As it covers the full fiscal year and contains audited financial statements, it is classified as an Annual Report (10-K). FY 2015
2016-02-25 Spanish
Corporate Governance Report - Faes Farma S.A.
Remuneration Information Classification · 99% confidence The document is titled "INFORME ANUAL SOBRE REMUNERACIONES DE LOS CONSEJEROS DE SOCIEDADES ANONIMAS COTIZADAS" (Annual Report on Remuneration of Directors of Listed Public Limited Companies). It explicitly details the remuneration policy, fixed and variable components, long-term savings plans, termination indemnities, and executive contract conditions for the Board of Directors for the fiscal year ending 31/12/2014. This content directly corresponds to the definition of a report detailing compensation for top executives and directors, which maps to the 'Remuneration Information' category. The specific code for this type of filing, based on the provided definitions, is DEF 14A (Proxy Solicitation & Information Statement often covers this, but DEF 14A is specifically listed for Remuneration Information in the provided schema definitions, which is a strong match for a detailed annual remuneration report). Checking the definitions: - 10-K: Too broad; this is a specific section/report. - AR: Not a general audit report. - DEF 14A: Description is "Report detailing compensation for top executives and directors." This is the most precise match for an 'Informe Anual sobre Remuneraciones'. Therefore, the classification is DEF 14A.
2015-03-06 Spanish
Audit Report / Information 2014
Audit Report / Information Classification · 98% confidence The document text explicitly contains the title "Informe de Auditoría Independiente de Cuentas Anuales Consolidadas" (Independent Auditor's Report on Consolidated Financial Statements) and includes the formal opinion from the auditor (KPMG Auditores S.L.) regarding the consolidated financial statements for the year ended December 31, 2014. It also references the accompanying 'Cuentas Anuales Consolidadas' (Consolidated Annual Accounts) and the 'Informe de gestión consolidado' (Consolidated Management Report). While it contains financial statements, the primary focus and structure of the provided text is the auditor's certification and opinion on those statements. This aligns best with the 'Audit Report / Information' category (AR), which covers standalone audit reports, even though it is attached to the annual accounts. FY 2014
2015-02-27 Spanish

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.